(NASDAQ: MRUS) Merus Nv's forecast annual revenue growth rate of 45.96% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.06%.
Merus Nv's revenue in 2024 is $43,947,000.On average, 6 Wall Street analysts forecast MRUS's revenue for 2024 to be $2,362,475,796, with the lowest MRUS revenue forecast at $578,782,840, and the highest MRUS revenue forecast at $3,506,845,228. On average, 5 Wall Street analysts forecast MRUS's revenue for 2025 to be $3,833,278,749, with the lowest MRUS revenue forecast at $1,630,431,260, and the highest MRUS revenue forecast at $5,666,284,004.
In 2026, MRUS is forecast to generate $8,448,261,602 in revenue, with the lowest revenue forecast at $591,516,062 and the highest revenue forecast at $24,945,540,404.